Rationale: Vascular tissues produce carbon monoxide (CO) via HO-dependent and HO-independent mechanisms; the former in tandem with biliverdin and iron and the latter as a lone product. CO has been shown to function as both a vasoconstrictor and vasodilator; however, factors that dictate the vasoregulatory phenotype of this gas are unknown. Objective: We investigated whether CO-mediated vasoconstriction is mechanistically linked to enhanced reactive oxygen species production that masks vasodilatory pathways. Key Words: carbon monoxide Ⅲ vascular reactivity Ⅲ reactive oxygen species Ⅲ oxidative stress Ⅲ antioxidant V ascular tissues generate carbon monoxide (CO) via heme oxygenase (HO)-dependent and HO-independent pathways. CO is liberated during heme metabolism by HO, with equimolar quantities of biliverdin and iron, whereas HO-independent sources of CO include oxidation of organic molecules and peroxidation of membrane lipids. 1,2 Following seminal reports that described a vasorelaxant effect of CO in the hepatic microcirculation, evidence supporting a vasodilatory role of CO has accumulated. 3,4 For example, pharmacological inhibition of HO product generation, presumably leading to a reduction in CO production, increases renal vascular resistance and constricts pressurized gracilis muscle arterioles. 5, 6 The functional role of HO in the vasculature, however, is not synonymous with the biological effects of CO because CO exerts pleiotropic actions in terms of vasoregulation, functioning as both a vasodilator and vasoconstrictor.
V ascular tissues generate carbon monoxide (CO) via heme oxygenase (HO)-dependent and HO-independent pathways. CO is liberated during heme metabolism by HO, with equimolar quantities of biliverdin and iron, whereas HO-independent sources of CO include oxidation of organic molecules and peroxidation of membrane lipids. 1, 2 Following seminal reports that described a vasorelaxant effect of CO in the hepatic microcirculation, evidence supporting a vasodilatory role of CO has accumulated. 3, 4 For example, pharmacological inhibition of HO product generation, presumably leading to a reduction in CO production, increases renal vascular resistance and constricts pressurized gracilis muscle arterioles. 5, 6 The functional role of HO in the vasculature, however, is not synonymous with the biological effects of CO because CO exerts pleiotropic actions in terms of vasoregulation, functioning as both a vasodilator and vasoconstrictor.
Exogenous CO was first shown to dilate rat coronary arteries and proposed to act in a manner similar to nitric oxide (NO); that is, via activation of soluble guanylate cyclase (sGC). 7, 8 The role of CO in regulating vascular tone has been proposed to be augmented under conditions in which NO bioavailability was reduced, a setting in which CO production was enhanced. 5, 9 CO has also been shown to hyperpolarize vascular smooth muscle via activation of calcium-activated potassium channels (K Ca ). 10, 11 Finally, CO was demonstrated to reduce constrictor responses to phenylephrine and 20-hydroxyeicosatetraenoic acid, while reducing the synthesis of the vasoconstrictor agent endothelin. 12, 13 Although the majority of data support a prodilatory role for CO, evidence for the existence of vasoconstrictor effects of CO has also accumulated. CO binds sGC with 30 to 100 fold less potency than NO; thus, the ability of this gas to efficiently activate sGC in physiological settings has been in question. 14 Moreover, CO has been proposed to inhibit NO synthesis and/or actions, interfering with the expression of vasodilatory mechanisms mediated by NO. 15, 16 Furthermore, both endogenous and exogenous CO were found to cause constriction of isolated rat gracilis muscle arterioles. 15 To date, the mechanism of CO-induced vasoconstriction has not been elucidated.
Relevant to the apparent discrepancy as to whether CO functions as a vasodilator or vasoconstrictor are findings that vascular endothelial cells exposed to CO undergo oxidative stress. 17 Because reactive oxygen species (ROS) have been implicated in pathways associated with direct vasoconstriction as well as impairment of vasodilation, we hypothesized that CO of vascular origin may promote vasoconstriction in a ROS-dependent manner. 18 -20 The present study was designed to investigate the vasoregulatory mechanisms associated with CO by examining the relationship between CO and ROS generation in rat renal arterial vessels.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Animals
Male Sprague-Dawley rats (250 to 300 g, Charles River, Wilmington, DE) were used in compliance with protocols approved by the Institutional Animal Care and Use Committee.
Assessment of Superoxide Production by Renal Vessels
Lucigenin chemiluminescence was used to measure superoxide (O 2 ⅐Ϫ ) production by freshly isolated renal interlobar arteries as per a protocol modified from Omar et al. 21 In an effort to further confirm levels of O 2 ⅐Ϫ production by vessels, an intravital fluorescence microscopy detection technique was used. O 2 ⅐Ϫ production by renal interlobar arteries was assessed by quantifying a fluorescent signal arising from oxidized dihydroethidium using a Nikon epifluorescence inverted microscope (Diaphot) outfitted with a SIT camera (Hamamatsu, Japan) as previously described. 22 
Assessment of H 2 O 2 and Peroxynitrite Generation by Renal Vessels
Freshly isolated renal interlobar arteries were exposed to authentic CO (1 mol/L) for 1 hour at 37°C in gas-sealed vials. Supernatant was collected for measurement of H 2 O 2 using Amplex red as previously described. 23 As an index of peroxynitrite (ONOO Ϫ ) formation, vessels were homogenized in K ϩ phosphate buffer, separated by SDS-PAGE, and probed with an anti-nitrotyrosine antibody (Millipore, 1:5000).
Detection of Isoprostane Production by Renal Vessels
Isoprostane production by renal interlobar arteries was assessed using the Cayman Chemical STAT-8-isoprostane EIA kit (CN-500431).
Assessment of Vascular Response to CO
Renal interlobular arteries were dissected into segments 1 to 2 mm in length and mounted on a pressure myograph (model CH/200/Q, Living System Instrumentation; Burlington, Vt) as previously described. 12 CO or the CO-releasing molecule (CORM)-3 was added to the superfusion buffer and changes in internal diameter were recorded. 24 The response to CO was studied in vascular preparations pretreated and not pretreated with tempol, ebselen, deferoxamine, N G -nitro-L-arginine methyl ester (L-NAME), apocynin, allopurinol, rotenone, carbonyl cyanide m-chlorophenylhydrazone (CCCP), pegylated superoxide dismutase (SOD), pegylated catalase, polyethylene glycol monomethyl ether, biliverdin, bilirubin, uric acid, indomethacin, or a thromboxane receptor (TP) antagonist (SQ29548). Finally, the effect of CO in vessels pretreated with tempol was examined in the absence and presence of an inhibitor of sGC 
Effect CO on SOD and Catalase Activities
SOD and catalase activity was quantified in vascular homogenates from vessels treated with and without CO (1 mol/L) at 37°C for 1 hour using commercial kits (Cayman Chemical 706002 and 707002, respectively).
Data Analysis
Data are expressed as meansϮSEM for the given number (n) of experiments. Results were analyzed by Student t test or by 2-way ANOVA and the Newman-Keuls post hoc test was performed. The null hypothesis was rejected at PϽ0.05.
Results

Effect of CO on Internal Diameter of Renal Arteries
Initial experiments were conducted to establish the vasoregulatory phenotype of CO in rat renal arteries under basal conditions. As shown in Figure 1A , exposure to authentic CO or the CO-releasing molecule CORM-3 reduced (PϽ0.05) internal diameter of interlobular arteries in a dose-dependent manner. Comparatively, vasoconstrictor response to 0.1 and 1.0 mol/L authentic CO correlated to 10 and 100 mol/L CORM-3, respectively. These findings are consistent with gas chromatographic/mass spectrometric detection of CO release by CORM-3 in physiological buffers, in which Ϸ1% of detectable CO recovery was observed (data not shown). Importantly, inactivated CORM-3, which does not actively release CO, had no effect on internal diameter of vessels. 
Effect of CO on ROS Generation by Renal Arteries
As shown in Figure 1B , freshly dissected vessels generate O 2 ⅐Ϫ ex vivo. Exposure of vessels to CORM-3 led to a dose-dependent increase in lucigenin-detectable O 2 ⅐Ϫ production that was Ϸ2-fold higher than baseline at 100 mol/L CORM-3 (PϽ0.05). Dihydroethidium fluorescence, an indicator of O 2 ⅐Ϫ production, was found to be stable in isolated renal arteries under basal conditions. Consistent with other detection methods, administration of CORM-3 led to a gradual increase in dihydroethidium-detectable O 2 ⅐Ϫ production over a period of 1 to 3 minutes before stabilizing and remaining elevated during a plateau phase ( Figure 1C ). Importantly, inactivated CORM-3 was found to have no effect on vascular Although O 2 ⅐Ϫ anion may be the initial ROS formed following exposure of renal arteries to CO, it is unclear whether other reactive intermediates are formed and/or propagate the vasoregulatory effects of CO. To this end, we examined the production of H 2 O 2 and nitrotyrosine, the latter an indicator of ONOO Ϫ formation, in vessels exposed to CO. We observed a slight increase in H 2 O 2 production that did not reach statistical significance, by renal interlobar arteries exposed to CO for 1 hour (3.54Ϯ1.1 versus 4.56Ϯ1.0 nmol/mg protein; nϭ6 and 7, respectively). Nitrotyrosine levels were undetectable under basal conditions and were unaltered following exposure to CO (data not shown).
Effect of Antioxidants on O 2 ⅐؊ Production and Vascular Response to CO
To further investigate the impact of oxidative stress on the vasoregulatory actions of CO, antioxidants known to preferentially target various ROS were applied. Tempol (1 mmol/ L), an SOD mimetic, prevented CORM-3-induced increase in O 2 ⅐Ϫ by renal arteries (Figure 2A ). Ebselen (1 mol/L) and deferoxamine (500 mol/L), a glutathione peroxidase mimetic and an iron chelator, respectively, similarly prevented (PϽ0.05) CORM-3 from promoting an increase in O 2 ⅐Ϫ . A link between CO-induced ROS generation and vasoregulation was established by the observations that tempol, ebselen, and deferoxamine prevented CO-induced vasoconstriction and uncovered a vasodilatory response to this gas ( Figure 2B ). A pegylated form of SOD (500 U/mL) was also effective at converting the response to CO from constriction to dilation ( Figure 2B ). The capacity of ebselen and deferoxamine to convert CO from constrictor to dilator, however, may implicate downstream ROS in these processes. Pretreatment of vessels with pegylated catalase (1000 U/mL) similarly converted the response of CO from constriction to dilation ( Figure 2B ). Polyethylene glycol monomethyl ether (125 g/mL), used as a control for pegylated SOD and catalase, had no effect on CO-mediated vasoconstriction ( Figure 2B ). Collectively, these findings implicate O 2 ⅐Ϫ and downstream intermediary reactive species in the implementation of the vasoregulatory actions of CO.
Effect of Inhibition of Vascular Oxidases on CO-Induced O 2 ⅐؊ Production and Vasoactivity
To investigate the contribution of various oxidases to the implementation of CO-induced oxidative stress and vasoactivity, the effects of this gas were studied in the absence and presence of inhibitors of the major sources of O 2 ⅐Ϫ in the vasculature: nitric oxide synthase (NOS), (NADPH)-oxidase, xanthine oxidase (XO), and the mitochondria. As shown in Figure 3 , inhibition of NOS, NADPH oxidase, and XO with L-NAME (1 mmol/L), apocynin (100 mol/L), and allopurinol (100 mol/L), respectively, inhibited CORM-3-induced elevation in O 2 ⅐Ϫ levels. Importantly, inhibition of NOS, NADPH oxidase, and XO also converted the response to CO from vasoconstriction to vasodilation (Figure 4) .
The mitochondrial respiration chain has been reported to differentially generate O 2 ⅐Ϫ depending on the specific activation or inhibition of particular oxidases. Rotenone (10 mol/ L), an inhibitor of complex I in the mitochondrial respiration chain did not alter O 2 ⅐Ϫ production or internal diameter in response to CORM-3 and CO (Figures 3 and 4D) , respectively. On the other hand, CCCP (5 mol/L), an inhibitor of complex IV minimized (PϽ0.05) CORM-3-induced O 2 ⅐Ϫ production by Ͼ70% (from 16Ϯ6.4 to 76.0Ϯ18.6 cpm/g in controls and from 30Ϯ2.4 to 46Ϯ5.7 cpm/g protein in vessels pretreated with CCCP) and converted CO from constrictor to dilator at 1000 nmol/L CO ( Figure 4D ).
Effect of Biliverdin and Bilirubin on O 2
⅐؊
Production and Vascular Response to CO
Consistent with previous reports demonstrating the antioxidant properties of biliverdin and bilirubin, 100 nmol/L either bile pigment inhibited the CORM-3-induced increase in O 2 ⅐Ϫ production ( Figure 5A ). Consistent with our initial findings using other antioxidants, biliverdin and bilirubin converted the response of CO from vasoconstriction to vasodilation in a concentration-dependent manner ( Figure 5B and 5C, respectively). Another endogenous antioxidant, uric acid (200 mol/L) also converted the response of renal arteries to CO from vasoconstriction to vasodilation (internal diameters of Ϫ3.0Ϯ0.0 versus 4.8Ϯ0.9 
Effect of Cyclooxygenase Inhibition and TP Receptor Antagonism on CO-Induced Vasoactivity
Pretreatment of renal interlobular arteries with indomethacin (1 mol/L) did not alter the vasoconstrictor response to CO, suggesting cyclooxygenase metabolites do not contribute to vasoconstrictor mechanisms associated with this gas ( Figure  6A ). On the other hand, blockade of the TP receptor (SQ29548; 1 mol/L) prevented (PϽ0.05) CO-induced vasoconstriction, implicating a non-thromboxane agonist of the TP receptor in mediating this response. Importantly, TP receptor blockade with SQ29548 had no effect on phenylephrine-induced (1 mol/L) reduction in internal diameter of renal vessels (Ϫ25.1Ϯ15 versus Ϫ27.3Ϯ1.0 m).
Oxidative stress promotes the formation of the vasoconstricting, nonenzymatic oxidation products of arachidonic acid known as isoprostanes. 25 We found that incubation of freshly isolated renal interlobar arteries with CO (10 mol/L) increased isoprostane formation from 201Ϯ47 to 393Ϯ60 pg/mg protein (PϽ0.05). Collectively, these observations suggest the contribution of an isoprostane to the vasoconstrictor actions of CO.
Effect of sGC Inhibition and K Ca Channel Blockade on CO-Induced Vasoactivity
Pretreatment of renal interlobular arteries with tempol allows for the expression of a CO-induced vasodilatory response ( Figure 6B ). In this experimental setting, the dilatory action of CO was partially reduced (PϽ0.05) by ODQ (10 mol/L) and completely prevented (PϽ0.05) by both TEA (1 mmol/L) and iberiotoxin (1 mol/L). The combination of TEA and ODQ also prevented the vasodilatory actions of CO. In the absence of tempol, both ODQ and TEA sensitized (PϽ0.05) vessels to CO-induced vasoconstriction. ODQ enhanced COinduced vasoconstriction from Ϫ5.0Ϯ0.6 to Ϫ7.3Ϯ0.6 m and from Ϫ12.8Ϯ0.9 to Ϫ18.0Ϯ1.9 m at 100 and 1000 nmol/L CO, respectively. TEA enhanced CO-induced vasoconstriction from Ϫ5.0Ϯ0.5 to Ϫ13.0Ϯ1.2 m and from Ϫ12.8Ϯ0.9 to Ϫ21.5Ϯ0.5 m, at 100 and 1000 nmol/L CO, respectively. 
Effect of CO on SOD and Catalase Activities
We then investigated the capacity of CO to alter the enzymatic activities of 2 critical antioxidative enzymes. The activities of SOD and catalase were measured in homogenates from vessels exposed to CO (1 mol/L) for 1 hour. CO did not significantly alter the activities of SOD (2.25Ϯ0.57 versus 1.39Ϯ0.04 U/mg protein in untreated and CO-treated, respectively) or catalase (22.4Ϯ3.3 versus 27.5Ϯ1.4 nmol H 2 O 2 conversion/mg protein per minute in untreated and CO-treated, respectively).
Discussion
Vascular tissues generate CO which, depending on experimental conditions, has been implicated in mediating vasoconstriction as well as vasodilation. 7, 8, 11, 15, 16 We report here for the first time that both the vasoconstrictor and vasodilatory responses to CO are critically conditioned by redox mechanisms ( Figure 7) . The vasoconstrictor action is linked to increased oxidant activity which promotes formation of isoprostanes. The vasodilatory action is linked to mechanisms involving sGC and K Ca channels, and requires conditions that offset the prooxidant activity of CO.
That CO and CORM-3 elicit constriction of isolated, pressurized, renal interlobular arteries is consistent with earlier reports that CO constricts pressurized gracilis muscle arterioles, an action attributed to inhibition of NO synthesis. 15 The present study offers an alternative explanation to the vasoconstrictor action of CO that involves oxidative stress as a determinant for the generation of isoprostanes, which promote contraction of vascular smooth muscle and thus mediate the constrictor action of the gas. Consistent with early reports of prooxidant actions of CO in endothelial cells and brain, we found that both authentic CO and CORM-3 cause as increase of O 2 ⅐Ϫ levels in renal interlobar arteries. 2, 17, 26 This action of CO may entail activation of multiple oxidases, because the CO-induced elevation of vascular O 2 ⅐Ϫ levels was blunted or minimized in arterial vessels pretreated with L-NAME (NOS inhibitor), apocynin (NADPH oxidase assembly inhibitor), allopurinol (XO inhibitor), or CCCP (mitochondrial oxidase complex IV inhibitor). Relevant to this point, CO is capable of binding and inhibiting NOS. 27, 28 It is unclear, however, whether NOS inhibition by CO is accompanied by uncoupling of the enzyme with resultant generation of O 2 ⅐Ϫ as occurs in the presence of tetrahydrobiopterin deficiency. Cytochrome c oxidase, a constituent of mitochondrial oxidase complex IV, is also amenable to inhibition by CO with attendant generation of ROS production. 29, 30 On the other hand, in respiratory epithelial cells, CO was reported to inhibit rather than to stimulate NADPH oxidase-dependent generation of O 2 ⅐Ϫ . 30 Given our finding that multiple oxidases appear to contribute to CO-induced elevation of vascular O 2 ⅐Ϫ , one should consider the possibility that a feed-forward cycle links the initial surge in O 2 ⅐Ϫ production via NOS uncoupling and/or cytochrome c oxidase inhibition, with the secondary activation of multiple oxidases by downstream intermediate prooxidant molecules such as H 2 O 2 , OH -radical and ONOO Ϫ . These are volatile molecules that can rapidly cycle between species via pathways such as the dismutation of O 2 ⅐Ϫ to H 2 O 2 , the conversion of H 2 O 2 and nitrite to ONOO Ϫ , the Fenton reaction-mediated generation of OH Ϫ radical, or the combination of O 2 ⅐Ϫ and NO to form ONOO Ϫ . 31 Previous studies offered evidence of feed-forward propagation of oxidative stress in the vasculature via H 2 O 2 -dependent activation of NADPH oxidases, XO, endothelial NOS uncoupling, and augmentation of intracellular iron. 32 Despite a previous report that CO increased intracellular H 2 O 2 production in the brain, the present observations that incubation of arterial vessels with CO failed to result in a significant augmentation of H 2 O 2 or nitrotyrosine levels (an index of ONOO Ϫ ) argues against the notion that H 2 O 2 and ONOO Ϫ are implicated in the propagation of the oxidative stress serving to sustain COinduced elevation of vascular O 2 ⅐Ϫ levels. 33 However, the possibility that CO-induced oxidative stress is sustained by intermediate reacting molecules via activation of multiple oxidases fits well with our finding that pretreatment of arterial vessels with ebselen (a glutathione peroxidase mimetic that also scavenges ONOO Ϫ ) or deferoxamine (a chelator of iron and other transition metals which limits OH Ϫ radical generation) prevents CO from increasing O 2 ⅐Ϫ . That deferoxamine blocked CO-induced increase in vascular O 2
⅐Ϫ
suggests that iron or other transition metals play a role in ROS propagation initiated by CO. Free iron can be deleterious to cells because of its participation in the Fenton reaction, which Figure 7 . Schematic demonstrating the dichotomous vasoregulatory actions of CO. CO alone may cause constriction of blood vessels via mechanisms associated with enhanced generation of ROS. On the other hand, concomitant production of biliverdin/bilirubin during heme metabolism or adequate redox balance maintenance by endogenous and/or exogenous antioxidants may suppress constrictor mechanisms associated with CO and allow for the expression of vasodilatory pathways that are masked by the primary oxidative stress response to this gas.
involves H 2 O 2 and yields OH
Ϫ radical, a highly reactive oxidant toxic to biological molecules. 34 That deferoxamine did not alter basal vascular levels of O 2 ⅐Ϫ may be taken to indicate that under resting conditions metal-driven reactions promoting oxidative stress are nominal.
We have also given consideration to the possibility that CO-induced elevation of vascular O 2 ⅐Ϫ levels results from an inhibitory action of the gas on antioxidant enzymes such as catalase and SOD. Catalase is a heme-containing enzyme which has been suggested to be a target for CO, leading to inhibition of its catalytic activity. 35 This is not the case in our study, because treatment with CO did not alter catalase activity measured in freshly isolated arterial vessels acutely exposed to the gas. Treatment with CO was also without effect on the activity of SOD measured in isolated arterial vessels. Recently, CO was reported to inhibit cystathionine ␤ synthase. 36 Inhibition of this enzyme may overwhelm endogenous antioxidative defense mechanisms via excessive homocysteine accumulation and/or a reduction in intracellular glutathione.
Linking the increase in O 2 ⅐Ϫ production to the vasoconstrictor actions of CO in renal arteries, we demonstrate that CO-induced vasoconstriction is converted to dilation by exogenous antioxidants and inhibition of intracellular sources of O 2 ⅐Ϫ . That a reduction in O 2 ⅐Ϫ levels prevents COmediated constriction confirms a role for ROS in the constrictor response. However, the ability of antioxidants to convert the actions of exogenous CO from constrictor to dilator suggests that ROS may be simultaneously preventing the expression of vasodilatory pathways. In the present study, dilation to CO in the presence of antioxidants was found to be mediated by activation of sGC and K Ca channels, consistent with reports in other resistance vessels. 11, 37 Interestingly, sGC and K channels have been shown to be negatively regulated by ROS. BK Ca (big conductance K Ca ) in rat cerebral arterial smooth muscle cells is reversibly inhibited by ONOO Ϫ , whereas ROS-mediated heme oxidation impairs sGC activation in blood vessels. 38, 39 Thus, antioxidant intervention may provide a dual impetus to both antagonize proconstrictor mechanisms, as well as to relieve inhibitory influences on vasodilator pathways (eg, K Ca , sGC) associated with oxidative stress.
The mechanism associated with CO-induced vasoconstriction, which appears to involve the generation of O 2 ⅐Ϫ and potentially downstream ROS, has not been elucidated to date. ROS are known to lead to the generation of nonenzymatic metabolites of arachidonic acid known as isoprostanes that are capable of constricting vessels via activation of the TP receptor. 25 As CO was found to enhance vascular isoprostane formation, we hypothesized that isoprostanes may be downstream mediators of CO-induced vasoconstriction. That a TP receptor antagonist, but not indomethacin, inhibited vasoconstriction to CO provides seminal evidence that isoprostanemediated activation of the TP receptor mediates CO-induced vasoconstriction.
Paradoxically, we observe vasoconstriction in response to exogenous CO, yet previous work has demonstrated that a reduction in endogenous CO formation via the inhibition of HO activity similarly promotes vasoconstriction. 5 These findings suggest that endogenously produced CO functions as a vasodilator, whereas exogenous CO functions as a vasoconstrictor. Because HO-mediated heme metabolism concurrently generates CO and endogenous antioxidants biliverdin/ bilirubin, we hypothesize that cogeneration of biliverdin/ bilirubin functions to neutralize prooxidant/-constrictor effects of endogenously formed CO. In fact, the prooxidant and pressor effects associated with angiotensin II-and DOCA salt-induced hypertension were reduced by elevated bilirubin levels. 40, 41 Consistent with previous reports of bile pigments functioning as antioxidants, exogenous biliverdin and bilirubin inhibited O 2 ⅐Ϫ production and vasoconstriction in response to CO. Concentrations of biliverdin and bilirubin used in the present study (10 to 1000 nmol/L) were consistent with previous work and believed to be in a physiological range, well below plasma concentrations (5 to 17 mol/L). 42 Ultimately, intracellular concentrations of biliverdin and bilirubin are contingent on lipid/water solubility, binding proteins, uptake/diffusion, and intracellular heme metabolism. Numerous mechanisms have been proposed regarding the antioxidant capacity of biliverdin and bilirubin. Perhaps the most impressive effects of bilirubin in terms of cellular protection is its ability to safeguard against lipid peroxidation. 42 Plasma bilirubin may function as a chain-breaking antioxidant, acting on secondary oxidants (eg, ONOO Ϫ ) involved in the propagation of ROS-mediated damage. 43, 44 Bilirubin was additionally shown to inhibit the activation process of NADPH oxidase, a major source of vascular O 2 ⅐Ϫ , and to inhibit protein kinase C activity-dependent ROS production. 45, 46 Furthermore, bilirubin may undergo a "recycling" process whereby biliverdin is converted to bilirubin via the enzyme biliverdin reductase, followed by bilirubin oxidation by ROS to biliverdin. 47 It should also be noted that other endogenous antioxidants may provide an alternative to bile pigments, such as in a setting in which CO is formed independently of HO. For example, uric acid has been previously shown to suppress ROS production in response to angiotensin II, and we demonstrate herein the ability of this compound to convert the response of CO from constrictor to dilator. 48 Collectively, these findings support the notion that the antioxidant capacity of endogenously formed compounds (biliverdin, bilirubin and uric acid) function to unmask dilatory mechanisms associated with CO.
It may be anticipated that acute administration of CO would elicit vasodilation, because biliverdin/bilirubin would be present when redox balance is in equilibrium; however, the present studies were conducted in an isolated, non-blood perfused system. Plasma bilirubin has been shown to have a large capacity to combat oxidative stress; therefore, lack of this pigment may reduced the antioxidant capacity of the vessel wall and allow for CO to elicit vasoconstriction. 42, 44 Therefore, the effects of CO may be largely dependent on environmental redox balance or, in some cases, experimental condition. 49 The debate as to whether CO of vascular origin functions as a vasodilator or vasoconstrictor has been fueled by conflicting reports in the literature. The role of HO in vasoregulation has oft focused on CO as the quintessential
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Redox Dictates CO-Mediated Vasoregulationbioactive product of heme metabolism; however, it may be prudent to consider that concurrent generation of biliverdin/ bilirubin is critical in dictating the vasoregulatory phenotype of CO. As such, these considerations may be applicable to systems outside of the vasculature, a concept that is consistent with the work of other investigators demonstrating synergistic actions of CO and biliverdin. 50 HO-independent sources of CO may also be physiologically relevant as CO formed as an isolated product likely increases ROS production, potentially leading to vasoconstriction. In conclusion, this study demonstrates, for the first time, that CO constricts renal arteries in a ROS-dependent manner that, when antagonized, allows for vasodilatory pathways associated with CO to become unmasked.
